In collaboration with global stakeholders, the PATH Diagnostics program conceptualizes, develops, commercializes, and ensures access to quality-assured diagnostic technologies that guide clinical decision-making, support surveillance, and inform health policies in low- and middle-income countries (LMIC). We combine market access capabilities with broad technical expertise in developing and scaling up innovative solutions to the world’s most pressing health challenges.